<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1329</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2018-11-70-76</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Monthly review: business activity of industry enterprises</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Romanova</surname><given-names>Svetlana</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2018-12-11" publication-format="electronic"><day>11</day><month>12</month><year>2018</year></pub-date><issue>11</issue><fpage>70</fpage><lpage>76</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>The rating was prepared using the national accounting statements of over 150 profitable industry manufacturers.</abstract><kwd-group xml:lang="en"><kwd>pharmaceutical industry</kwd><kwd>medical industry</kwd><kwd>manufacturers</kwd><kwd>medicinal products</kwd><kwd>prosthetic and orthopedic devices</kwd><kwd>efficiency ratio</kwd><kwd>return on assets</kwd><kwd>investment attractiveness</kwd><kwd>analysis</kwd><kwd>rating</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фармацевтическая промышленность</kwd><kwd>медицинская промышленность</kwd><kwd>предприятия</kwd><kwd>лекарственные средства</kwd><kwd>протезно-ортопедические средства</kwd><kwd>показатели деловой активности</kwd><kwd>рентабельность собственного капитала</kwd><kwd>прибыль от реализации</kwd><kwd>анализ</kwd><kwd>рейтинг</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Романова С.А., Захарова В.М. Рейтинг предприятий медицинской промышленности за 1 полугодие 2002 года. Ремедиум, 2002; 10: 60-69.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Романова С.А. Деловая активность предприятий фармпромышленности: рейтинг по рентабельности собственного капитала за 2015 год. Ремедиум, 2017; 11: 58-61.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Романова С.А. Рейтинг инвестиционной привлекательности протезно-ортопедических предприятий по результатам 2014 года. Ремедиум, 2017; 10: 73-76.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>http://www.finanalis.ru.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>http://afdanalyse.ru/publ/finansovyj_analiz/ fin_koefitcienti.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>http://www.finchas.ru.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>http://polbu.ru/kovalev_ecanalysis/ch53_all. html.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>http://bp.ds31.ru/articles.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>http://allfi.biz.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>http://infobank.by/1594/default.</mixed-citation></ref></ref-list></back></article>
